Search words under length of 4 characters are not processed.
1631 results:
1481. ChemDiv, Torrey Pines Investment and DZNE Announce Research Collaboration  
DZNE, ChemDiv, Inc. and Torrey Pines Investment jointly announced today an agreement initiating a Research and Development collaboration targeting pathways and molecular mechanisms underlying…  
1482. Researchers activate repair program for nerve fibers  
Scientists of the DZNE have succeeded in releasing a molecular brake that prevents the regeneration of nerve connections. Researchers led by neurobiologist Frank Bradke report on these findings in…  
1483. Aberrant Tau Proteins Put Neuronal Networks to Sleep: Drug “Rolofylline” a Possible Antidote  
The report which is based on laboratory studies suggests that the drug “Rolofylline” could possibly alleviate learning and memory problems associated with aggregating Tau proteins. Bonn (Germany),…  
1484. United against Dementia among Children and Adults  
Learning from each other, joint research and as such make new therapies against childhood and senile dementia more tangible – this is what the DZNE and the NCL Foundation, now want to push ahead.…  
1485. Alzheimer’s: Cellular Mechanism Provides Explanation Model for Declining Memory Performance  
Loss of neuronal contacts impairs nerve cells that control activity of the hippocampus. Martin Fuhrmann and co-workers report on these findings in “Neuron”. Loss of neuronal contacts impairs nerve…  
1486. Federal President Gauck visits German Center for Neurodegenerative Diseases  
Today Joachim Gauck and his partner Daniela Schadt informed themself about the diverse research at DZNE. Bonn, September 1st, 2016. Today, the Federal President Joachim Gauck visited the DZNE at the…  
1487. A New Biomarker for Nerve Cell Damage  
Scientists at the German Center for Neurodegenerative Diseases (DZNE), the Hertie Institute for Clinical Brain Research and the University of Tübingen have identified proteins in the blood and…  
1488. UW-Madison delegation heads to DZNE in Germany for Alzheimer's, Dementia Research  
A delegation of about a dozen UW-Madison research scientists will travel to Bonn and will share insights and information on the increasingly prevalent disease. Bonn/Madison, March 10th, 2016. A…  
1489. DZNE and Orion Corporation start strategic collaboration  
DZNE and Orion Corporation have agreed to start a strategic collaboration. They want to identify novel drug targets and develop treatments for neurodegenerative disorders. Bonn/Helsinki, March,…  
1490. DZNE-research impacts German legislation  
Scientific results of the DZNE-led study "Dementia Networks in Germany (DemNet-D)" were considered in a new German law to strengthen health care for people with dementia. This law enables statutory…  
Search results 1481 until 1490 of 1631

Welcome to our website, here you can inform yourself basically cookie-free.

We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.

Your browser allows the setting of cookies: